Association of systemic immune-inflammation index with severity in acute ischemic stroke patients: a cross-sectional study
Abstract
Objective To investigate the association between the Systemic Immune-Inflammation Index (SII) and the severity of acute ischemic stroke (AIS), as measured by the National Institutes of Health Stroke Scale (NIHSS), and to explore its potential as a predictive marker for clinical outcomes. Methods We used the data of 1723 AIS patients in the Stroke Center of Quzhou People’s Hospital from September 2016 to September 2022 for a cross-sectional study. SII was calculated as platelet count × neutrophil count divided by lymphocyte count. Stroke severity was classified as mild (NIHSS < 8) or severe (NIHSS ≥ 8). Multivariable logistic regression and subgroup analyses were performed to evaluate the relationship between SII levels and NIHSS scores, adjusting for confounders such as age, sex, and comorbidities. Nonlinear associations and threshold effects were further assessed using smooth curve fitting. Results Elevated SII levels were independently associated with higher stroke severity (OR: 1.04, 95% CI: 1.01–1.07). A nonlinear relationship was identified, with a critical range of SII/100 values (2.4–7.8) demonstrating the strongest correlation with NIHSS scores. Patients in the highest SII quartile (Q4) exhibited a 3.46-fold increase in odds of severe stroke compared to those in the lowest quartile (Q1) (p < 0.001). Subgroup analyses confirmed the robustness of these findings across diverse demographic and clinical profiles. Conclusion SII is a robust biomarker for predicting stroke…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 1,723 participants or records.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.